Earlier this week, the U.S. Food and Drug Administration announced a significant recall of over 7,100 bottles of duloxetine, a generic form of the popular antidepressant Cymbalta. The recall was ...
More than 233,000 bottles of an antidepressant have been recalled by public health officials due to a chemical containing the risk of cancer. The U.S. Food and Drug Administration classified capsules ...
A nationwide recall of more than 233,000 bottles of duloxetine, an anti-depressant, has been announced by the Food and Drug Administration for possibly containing a chemical increasing the risk of ...
The results of the current investigation are based on the initial 12-week, open-label acute treatment phase of a randomized withdrawal study of duloxetine in the prevention of relapse of MDD. Results ...
In patients receiving serotonergic medications in combination with an MAOI, there have been reports of serious and sometimes fatal reactions, including hyperthermia, rigidity, myoclonus, autonomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results